Correlation of pre-treatment tumor mRNA expression with XPF and MUS81 protein expression, measured by IHC composite score, showed a statistically significant association between ERCC1 mRNA expression and XPF protein levels (P = 0.041) in the clinical samples. Here, ERCC4 is linked to neoplasm.